메뉴 건너뛰기




Volumn 9, Issue 10, 2014, Pages

Acid suppression therapy does not predispose to Clostridium difficile infection: The case of the potential Bias

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

EID: 84908409407     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110790     Document Type: Article
Times cited : (49)

References (32)
  • 1
    • 55249105923 scopus 로고    scopus 로고
    • Clostridium difficile-more difficult than ever
    • Kelly CP, LaMont JT (2008) Clostridium difficile-more difficult than ever. New England Journal of Medicine 359 (18): 1932-40.
    • (2008) New England Journal of Medicine , vol.359 , Issue.18 , pp. 1932-1940
    • Kelly, C.P.1    LaMont, J.T.2
  • 2
    • 65449155189 scopus 로고    scopus 로고
    • Clostridium difficile infection caused by the epidemic bi/nap1/027 strain
    • O'Connor JR, Johnson S, Gerding DN (2009) Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136 (6): 1913-24.
    • (2009) Gastroenterology , vol.136 , Issue.6 , pp. 1913-1924
    • O'Connor, J.R.1    Johnson, S.2    Gerding, D.N.3
  • 3
    • 25144469664 scopus 로고    scopus 로고
    • Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe
    • Warmy M, Pepin J, Fang A, Killgore G, Thompson A, et al. (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366: 9491.
    • (2005) Lancet , vol.366 , pp. 9491
    • Warmy, M.1    Pepin, J.2    Fang, A.3    Killgore, G.4    Thompson, A.5
  • 4
    • 0036129083 scopus 로고    scopus 로고
    • Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea iMorbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals
    • Miller MA, Hyland M, Ofner-Agostini M, Gourdeau M, Ishak M, et al Canadian Hospital Epidemiology Committee. Canadian Nosocomial Infection Surveillance. (2002) Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea iMorbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 23 (3): 137-40.
    • (2002) Infect Control Hosp Epidemiol , vol.23 , Issue.3 , pp. 137-140
    • Miller, M.A.1    Hyland, M.2    Ofner-Agostini, M.3    Gourdeau, M.4    Ishak, M.5    Canadian Nosocomial Infection Surveillance6
  • 5
    • 38049084783 scopus 로고    scopus 로고
    • Update on the changing epidemiology of clostridium difficile-associated disease
    • McFarland LV (2008) Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 5 (1): 40-8.
    • (2008) Nat Clin Pract Gastroenterol Hepatol , vol.5 , Issue.1 , pp. 40-48
    • McFarland, L.V.1
  • 6
    • 39749120072 scopus 로고    scopus 로고
    • Antimicrobial-associated risk factors for Clostridium difficile infection
    • Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA (2008) Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 46 (Suppl 1): S19-31.
    • (2008) Clin Infect Dis , vol.46 , pp. S19-S31
    • Owens, R.C.1    Donskey, C.J.2    Gaynes, R.P.3    Loo, V.G.4    Muto, C.A.5
  • 7
    • 60349093694 scopus 로고    scopus 로고
    • Predictors of serious complications due to clostridium difficile infection
    • Gujja D, Friedenberg FK (2009) Predictors of serious complications due to Clostridium difficile infection. Aliment Pharmacol Ther 29 (6): 635-42.
    • (2009) Aliment Pharmacol Ther , vol.29 , Issue.6 , pp. 635-642
    • Gujja, D.1    Friedenberg, F.K.2
  • 8
    • 0036845101 scopus 로고    scopus 로고
    • Underlying disease severity as a major risk factor for nosocomial clostridium difficile diarrhea
    • Kyne L, Sougioultzis S, McFarland LV, Kelly CP (2002) Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemio 23(11): 653-9.
    • (2002) Infect Control Hosp Epidemio , vol.23 , Issue.11 , pp. 653-659
    • Kyne, L.1    Sougioultzis, S.2    McFarland, L.V.3    Kelly, C.P.4
  • 9
    • 0031752883 scopus 로고    scopus 로고
    • Risk factors for clostridium difficile infection
    • Bignardi GE (1998) Risk factors for Clostridium difficile infection. J Hosp Infect 40: 1-15.
    • (1998) J Hosp Infect , vol.40 , pp. 1-15
    • Bignardi, G.E.1
  • 10
    • 0020062279 scopus 로고
    • Antibiotic-associated pseudomembranous colitis: An epidemiologic investigation of a cluster of cases
    • Pierce PF Jr, Wilson R, Silva J Jr, Garagusi VF, Rifkin GD, et al. (1982) Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases. J Infect Dis 145: 269-74.
    • (1982) J Infect Dis , vol.145 , pp. 269-274
    • Pierce, P.F.1    Wilson, R.2    Silva, J.3    Garagusi, V.F.4    Rifkin, G.D.5
  • 11
    • 44849131030 scopus 로고    scopus 로고
    • Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficileassociated disease
    • Choudhry MN, Soran H, Ziglam HM (2008) Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficileassociated disease. QJM. 101 (6): 445-8.
    • (2008) QJM , vol.101 , Issue.6 , pp. 445-448
    • Choudhry, M.N.1    Soran, H.2    Ziglam, H.M.3
  • 12
    • 48749087340 scopus 로고    scopus 로고
    • Is over-use of proton pump inhibitors fuelling the current epidemic of clostridium difficile-associated diarrhoea?
    • Cunningham R, Dial S (2008) Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea? J Hosp Infect 70 (1): 1-6.
    • (2008) J Hosp Infect , vol.70 , Issue.1 , pp. 1-6
    • Cunningham, R.1    Dial, S.2
  • 13
    • 84892373793 scopus 로고    scopus 로고
    • Inappropriate Use of Gastric Acid Suppression Therapy in Hospitalized Patients with Clostridium difficile-Associated Diarrhea: A Ten-Year Retrospective Analysis
    • Rashid S, Rajan D, Iqbal J, Lipka S, Jacob R, et al. (2012) Inappropriate Use of Gastric Acid Suppression Therapy in Hospitalized Patients with Clostridium difficile-Associated Diarrhea: A Ten-Year Retrospective Analysis. ISRN Gastroenterol: 902320.
    • (2012) ISRN Gastroenterol , pp. 902320
    • Rashid, S.1    Rajan, D.2    Iqbal, J.3    Lipka, S.4    Jacob, R.5
  • 14
    • 50649112615 scopus 로고    scopus 로고
    • Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients
    • Aseeri M, Schroeder T, Kramer J, Zackula R (2008) Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol 103 (9): 2308-13.
    • (2008) Am J Gastroenterol , vol.103 , Issue.9 , pp. 2308-2313
    • Aseeri, M.1    Schroeder, T.2    Kramer, J.3    Zackula, R.4
  • 15
    • 29144473282 scopus 로고    scopus 로고
    • Use of gastric acid-suppressive agents and the risk of community-acquired clostridium difficile-associated disease
    • Dial S, Delaney JA, Barkun AN, Suissa S (2005) Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294 (23): 2989-95.
    • (2005) JAMA , vol.294 , Issue.23 , pp. 2989-2995
    • Dial, S.1    Delaney, J.A.2    Barkun, A.N.3    Suissa, S.4
  • 16
    • 36448981751 scopus 로고    scopus 로고
    • Association of proton-pump inhibitors with outcomes in clostridium difficile colitis
    • Cadle RM, Mansouri MD, Logan N, Kudva DR, Musher DM (2007) Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm 64 (22): 2359-63.
    • (2007) Am J Health Syst Pharm , vol.64 , Issue.22 , pp. 2359-2363
    • Cadle, R.M.1    Mansouri, M.D.2    Logan, N.3    Kudva, D.R.4    Musher, D.M.5
  • 17
    • 60349116490 scopus 로고    scopus 로고
    • Proton pump inhibitors increase significantly the risk of clostridium difficile infection in a low-endemicity, non-outbreak hospital setting
    • Dalton BR, Lye-Maccannell T, Henderson EA, Maccannell DR, Louie TJ (2009) Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting. Aliment Pharmacol Ther 29 (6): 626.
    • (2009) Aliment Pharmacol Ther , vol.29 , Issue.6 , pp. 626
    • Dalton, B.R.1    Lye-Maccannell, T.2    Henderson, E.A.3    Maccannell, D.R.4    Louie, T.J.5
  • 18
    • 84866371914 scopus 로고    scopus 로고
    • Clostridium difficile infection and proton pump inhibitors
    • Pohl JF (2012) Clostridium difficile infection and proton pump inhibitors. Curr Opin Pediat 24 (5): 627-31.
    • (2012) Curr Opin Pediat , vol.24 , Issue.5 , pp. 627-631
    • Pohl, J.F.1
  • 19
    • 34547635096 scopus 로고    scopus 로고
    • Vegetative clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: A potential mechanism to explain the association between proton pump inhibitors and c. Difficile-associated diarrhea?
    • Jump RL, Pultz MJ, Donskey CJ (2007) Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob Agents Chemother 51 (8): 2883-7.
    • (2007) Antimicrob Agents Chemother , vol.51 , Issue.8 , pp. 2883-2887
    • Jump, R.L.1    Pultz, M.J.2    Donskey, C.J.3
  • 20
    • 27444437759 scopus 로고    scopus 로고
    • Emergence of fluoroquinolones as the predominant risk factor for clostridium difficile-associated diarrhea: A cohort study during an epidemic in quebec
    • Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, et al. (2005) Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41 (9): 1254-60.
    • (2005) Clin Infect Dis , vol.41 , Issue.9 , pp. 1254-1260
    • Pépin, J.1    Saheb, N.2    Coulombe, M.A.3    Alary, M.E.4    Corriveau, M.P.5
  • 21
    • 84908428195 scopus 로고    scopus 로고
    • Food and Drug (2012) FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs)
    • Availebl September
    • Administration, U.S. Food and Drug (2012) FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs). U.S. Food and Drug Administration. Availebl: http://www.fda.gov/Drugs/DrugSafety/ucm290510. htm#sa. Accessed: September 8, 2014.
    • (2014) U.S. Food and Drug Administration , vol.8
    • Administration, U.S.1
  • 22
    • 77952155563 scopus 로고    scopus 로고
    • Iatrogenic gastric acid suppression and the risk of nosocomial clostridium difficile infection
    • Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, et al. (2010) Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 170 (9): 784-90.
    • (2010) Arch Intern Med , vol.170 , Issue.9 , pp. 784-790
    • Howell, M.D.1    Novack, V.2    Grgurich, P.3    Soulliard, D.4    Novack, L.5
  • 23
    • 84908428194 scopus 로고    scopus 로고
    • UpToDate Accessed September
    • Antibiotics C diff PPI. UpToDate . Available: www.uptodate.com/store. Accessed September 8, 2014.
    • (2014) , vol.8
    • Antibiotics C diff PPI1
  • 24
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
    • Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (5): 373-83.
    • (1987) J Chronic Dis , vol.40 , Issue.5 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.L.3    MacKenzie, C.R.4
  • 25
    • 33746413402 scopus 로고    scopus 로고
    • Proton pump inhibitor therapy is a risk factor for clostridium difficile-associated diarrhoea
    • Yearsley KA, Gilby LJ, Ramadas AV, Kubiak EM, Fone DL, et al. (2006) Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Aliment Pharmacol Ther 24 (4): 613-9.
    • (2006) Aliment Pharmacol Ther , vol.24 , Issue.4 , pp. 613-619
    • Yearsley, K.A.1    Gilby, L.J.2    Ramadas, A.V.3    Kubiak, E.M.4    Fone, D.L.5
  • 26
    • 81355160270 scopus 로고    scopus 로고
    • Systematic review: The use of proton pump inhibitors and increased susceptibility to enteric infection
    • Bavishi C, Dupont HL (2011) Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther 34 (11-12): 1269-81.
    • (2011) Aliment Pharmacol Ther , vol.34 , Issue.11-12 , pp. 1269-1281
    • Bavishi, C.1    Dupont, H.L.2
  • 27
    • 84896454372 scopus 로고    scopus 로고
    • Medication risk factors associated with healthcare-associated clostridium difficile infection: A multilevel model case-control study among 64 US academic medical centres
    • Pakyz AL, Jawahar R, Wang Q, Harpe SE (2014) Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres. J Antimicrob Chemother 69(4):1127-31.
    • (2014) J Antimicrob Chemother , vol.69 , Issue.4 , pp. 1127-1131
    • Pakyz, A.L.1    Jawahar, R.2    Wang, Q.3    Harpe, S.E.4
  • 28
    • 0034054649 scopus 로고    scopus 로고
    • Gastric acid suppression does not promote clostridial diarrhoea in the elderly
    • Shah S, Lewis A, Leopold D, Dunstan F, Woodhouse K (2000) Gastric acid suppression does not promote clostridial diarrhoea in the elderly. QJM 93 (3): 175-81.
    • (2000) QJM , vol.93 , Issue.3 , pp. 175-181
    • Shah, S.1    Lewis, A.2    Leopold, D.3    Dunstan, F.4    Woodhouse, K.5
  • 29
    • 35348853726 scopus 로고    scopus 로고
    • Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a veterans Administration health care system
    • McFarland LV, Clarridge JE, Beneda HW, Raugi GJ (2007) Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. Clin Infect Dis 45 (9): 1141-51.
    • (2007) Clin Infect Dis , vol.45 , Issue.9 , pp. 1141-1151
    • McFarland, L.V.1    Clarridge, J.E.2    Beneda, H.W.3    Raugi, G.J.4
  • 30
    • 78149401686 scopus 로고    scopus 로고
    • The effect of hospital-acquired clostridium difficile infection on in-hospital mortality
    • Oake N, Taljaard M, van Walraven C, Wilson K, Roth V, et al. (2010) The effect of hospital-acquired Clostridium difficile infection on in-hospital mortality. Arch Intern Med 170 (20): 1804-10.
    • (2010) Arch Intern Med , vol.170 , Issue.20 , pp. 1804-1810
    • Oake, N.1    Taljaard, M.2    Van Walraven, C.3    Wilson, K.4    Roth, V.5
  • 32
    • 84863717616 scopus 로고    scopus 로고
    • Risk of clostridium difficile infection with acid suppressing drugs and antibiotics: Metaanalysis
    • Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, et al. (2012) Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: metaanalysis. Am J Gastroenterol 107(7):1011-9.
    • (2012) Am J Gastroenterol , vol.107 , Issue.7 , pp. 1011-1019
    • Kwok, C.S.1    Arthur, A.K.2    Anibueze, C.I.3    Singh, S.4    Cavallazzi, R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.